Tower Research Capital LLC TRC lifted its position in shares of The Clorox Company (NYSE:CLX – Free Report) by 100.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,377 shares of the company’s stock after buying an additional 5,710 shares during the period. Tower Research Capital LLC TRC’s holdings in Clorox were worth $1,848,000 as of its most recent SEC filing.
Several other large investors have also made changes to their positions in CLX. Integral Investment Advisors Inc. increased its stake in Clorox by 4.1% during the fourth quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company’s stock worth $279,000 after acquiring an additional 67 shares during the last quarter. HCR Wealth Advisors increased its position in Clorox by 1.0% during the 4th quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock worth $1,116,000 after purchasing an additional 68 shares in the last quarter. Sound View Wealth Advisors Group LLC lifted its position in Clorox by 6.1% during the fourth quarter. Sound View Wealth Advisors Group LLC now owns 1,345 shares of the company’s stock valued at $218,000 after buying an additional 77 shares in the last quarter. Wedbush Securities Inc. grew its stake in Clorox by 1.2% during the fourth quarter. Wedbush Securities Inc. now owns 7,624 shares of the company’s stock worth $1,238,000 after buying an additional 94 shares during the period. Finally, Brooklyn Investment Group increased its position in shares of Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after acquiring an additional 95 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several research firms recently weighed in on CLX. UBS Group reduced their target price on shares of Clorox from $176.00 to $154.00 and set a “neutral” rating on the stock in a report on Thursday, April 17th. Barclays lowered their target price on Clorox from $139.00 to $134.00 and set an “underweight” rating for the company in a research note on Friday, April 11th. Evercore ISI boosted their price target on Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Citigroup lowered their price objective on shares of Clorox from $165.00 to $150.00 and set a “neutral” rating for the company in a research report on Monday, April 14th. Finally, StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $153.83.
Clorox Trading Up 2.4 %
NYSE:CLX opened at $141.99 on Wednesday. The company has a market cap of $17.49 billion, a PE ratio of 38.80, a P/E/G ratio of 2.62 and a beta of 0.61. The business’s 50 day moving average is $146.19 and its two-hundred day moving average is $156.10. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37.
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the previous year, the firm earned $2.16 EPS. On average, analysts predict that The Clorox Company will post 7.15 EPS for the current year.
Clorox Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be paid a $1.22 dividend. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.44%. Clorox’s payout ratio is currently 133.33%.
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- What is the FTSE 100 index?
- How to Invest in Micro-Cap Stocks Like a Pro
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Investors Sell Microsoft Stock on OpenAI News—Time to Buy?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Take-Two Interactive: A Defensive Play Set to Explode
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.